athenahealth, Inc, a leading provider of network-enabled software and services for medical groups and health systems nationwide, and Smile Foundation announced the expansion of...
AbbVie announced key results from a phase 2 study of upadacitinib given as monotherapy, or in combination therapy (ABBV-599) with elsubrutinib, a kinase inhibitor...
Contexture, the largest health information organization in the western U.S. serving Arizona and Colorado, announced plans to transition to a unified technology platform for...
C2N Diagnostics, a leader in advanced brain health diagnostics, announced the presentation of two research studies at the AD/PD 2023 International Conference on Alzheimer’s...
Picarro, Inc. announced the successful validation and use of the company's Cavity Ring-Down Spectroscopy (CRDS) under Other Test Method 47 (OTM-47) as published by the Environmental...
